HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Cardiology
RCT
Mendelian randomization links higher plasma EPA to increased ischemic heart disease odds
Omega 3 supplements may not lower heart disease risk
This two-sample Mendelian randomization analysis in participants of European descent found a higher odds of ischemic heart disease with a on…
New genetic research suggests omega 3 supplements might not reduce heart disease risk in the general population despite lowering triglycerid…
medRxiv
Apr 29, 2026
Cardiology
Sys. Review
Narrative review covers cardiovascular conditions and cognitive decline without reported trial data
Your Heart and Brain Are Talking to Each Other
This narrative review addresses a broad scope of cardiovascular conditions, including stroke, heart failure, atrial fibrillation, and ischem…
Imagine your heart and brain as two best friends who never stop texting each other.
Frontiers
Apr 22, 2026
Genetics & Precision Medicine
Observational Cohort Study Links Dynamic Cardiac Shape to Cardiometabolic Disease Risk in UK Biobank
New Scan Tracks Heart Motion to Predict Disease Risk Better
This observational cohort study abstract analyzes UK Biobank participants to assess dynamic cardiac shape associations with incident cardiom…
How your heart moves during a beat predicts future disease risk better than just measuring its size on a standard scan.
medRxiv
Apr 21, 2026
Cardiology
One-year post-CABG diastolic function worsens despite preserved ejection fraction in ischemic heart disease patients.
Heart Surgery Makes Pumping Harder Later
This observational review assessed cardiac mechanics in 96 patients undergoing elective coronary artery bypass grafting (CABG) compared to b…
Even when heart surgery restores blood flow, the heart muscle may struggle to relax and fill properly a year later.
medRxiv
Apr 15, 2026
Cardiology
RCT
Intensive medical treatment failed to reduce major adverse cardiovascular events in women with suspected ANOCA/INOCA over 2.5 years.
Intensive heart medication did not reduce major events in women with suspected ANOCA
This randomized controlled trial enrolled 2,476 women with suspected ANOCA/INOCA across 71 US sites. Over a 2.5-year follow-up, intensive me…
Intensive heart medication did not reduce major events in women with suspected ANOCA, finding that aggressive treatment offered no benefit o…
Apr 6, 2026